Cargando…

Understanding the P-Loop Conformation in the Determination of Inhibitor Selectivity Toward the Hepatocellular Carcinoma-Associated Dark Kinase STK17B

As a member of the death-associated protein kinase family of serine/threonine kinases, the STK17B has been associated with diverse diseases such as hepatocellular carcinoma. However, the conformational dynamics of the phosphate-binding loop (P-loop) in the determination of inhibitor selectivity prof...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Chang, Li, Zhizhen, Liu, Zonghan, Yang, Shiye, Wang, Qing, Chai, Zongtao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9127184/
https://www.ncbi.nlm.nih.gov/pubmed/35620482
http://dx.doi.org/10.3389/fmolb.2022.901603
_version_ 1784712294141263872
author Liu, Chang
Li, Zhizhen
Liu, Zonghan
Yang, Shiye
Wang, Qing
Chai, Zongtao
author_facet Liu, Chang
Li, Zhizhen
Liu, Zonghan
Yang, Shiye
Wang, Qing
Chai, Zongtao
author_sort Liu, Chang
collection PubMed
description As a member of the death-associated protein kinase family of serine/threonine kinases, the STK17B has been associated with diverse diseases such as hepatocellular carcinoma. However, the conformational dynamics of the phosphate-binding loop (P-loop) in the determination of inhibitor selectivity profile to the STK17B are less understood. Here, a multi-microsecond length molecular dynamics (MD) simulation of STK17B in the three different states (ligand-free, ADP-bound, and ligand-bound states) was carried out to uncover the conformational plasticity of the P-loop. Together with the analyses of principal component analysis, cross-correlation and generalized correlation motions, secondary structural analysis, and community network analysis, the conformational dynamics of the P-loop in the different states were revealed, in which the P-loop flipped into the ADP-binding site upon the inhibitor binding and interacted with the inhibitor and the C-lobe, strengthened the communication between the N- and C-lobes. These resulting interactions contributed to inhibitor selectivity profile to the STK17B. Our results may advance our understanding of kinase inhibitor selectivity and offer possible implications for the design of highly selective inhibitors for other protein kinases.
format Online
Article
Text
id pubmed-9127184
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-91271842022-05-25 Understanding the P-Loop Conformation in the Determination of Inhibitor Selectivity Toward the Hepatocellular Carcinoma-Associated Dark Kinase STK17B Liu, Chang Li, Zhizhen Liu, Zonghan Yang, Shiye Wang, Qing Chai, Zongtao Front Mol Biosci Molecular Biosciences As a member of the death-associated protein kinase family of serine/threonine kinases, the STK17B has been associated with diverse diseases such as hepatocellular carcinoma. However, the conformational dynamics of the phosphate-binding loop (P-loop) in the determination of inhibitor selectivity profile to the STK17B are less understood. Here, a multi-microsecond length molecular dynamics (MD) simulation of STK17B in the three different states (ligand-free, ADP-bound, and ligand-bound states) was carried out to uncover the conformational plasticity of the P-loop. Together with the analyses of principal component analysis, cross-correlation and generalized correlation motions, secondary structural analysis, and community network analysis, the conformational dynamics of the P-loop in the different states were revealed, in which the P-loop flipped into the ADP-binding site upon the inhibitor binding and interacted with the inhibitor and the C-lobe, strengthened the communication between the N- and C-lobes. These resulting interactions contributed to inhibitor selectivity profile to the STK17B. Our results may advance our understanding of kinase inhibitor selectivity and offer possible implications for the design of highly selective inhibitors for other protein kinases. Frontiers Media S.A. 2022-05-10 /pmc/articles/PMC9127184/ /pubmed/35620482 http://dx.doi.org/10.3389/fmolb.2022.901603 Text en Copyright © 2022 Liu, Li, Liu, Yang, Wang and Chai. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Molecular Biosciences
Liu, Chang
Li, Zhizhen
Liu, Zonghan
Yang, Shiye
Wang, Qing
Chai, Zongtao
Understanding the P-Loop Conformation in the Determination of Inhibitor Selectivity Toward the Hepatocellular Carcinoma-Associated Dark Kinase STK17B
title Understanding the P-Loop Conformation in the Determination of Inhibitor Selectivity Toward the Hepatocellular Carcinoma-Associated Dark Kinase STK17B
title_full Understanding the P-Loop Conformation in the Determination of Inhibitor Selectivity Toward the Hepatocellular Carcinoma-Associated Dark Kinase STK17B
title_fullStr Understanding the P-Loop Conformation in the Determination of Inhibitor Selectivity Toward the Hepatocellular Carcinoma-Associated Dark Kinase STK17B
title_full_unstemmed Understanding the P-Loop Conformation in the Determination of Inhibitor Selectivity Toward the Hepatocellular Carcinoma-Associated Dark Kinase STK17B
title_short Understanding the P-Loop Conformation in the Determination of Inhibitor Selectivity Toward the Hepatocellular Carcinoma-Associated Dark Kinase STK17B
title_sort understanding the p-loop conformation in the determination of inhibitor selectivity toward the hepatocellular carcinoma-associated dark kinase stk17b
topic Molecular Biosciences
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9127184/
https://www.ncbi.nlm.nih.gov/pubmed/35620482
http://dx.doi.org/10.3389/fmolb.2022.901603
work_keys_str_mv AT liuchang understandingtheploopconformationinthedeterminationofinhibitorselectivitytowardthehepatocellularcarcinomaassociateddarkkinasestk17b
AT lizhizhen understandingtheploopconformationinthedeterminationofinhibitorselectivitytowardthehepatocellularcarcinomaassociateddarkkinasestk17b
AT liuzonghan understandingtheploopconformationinthedeterminationofinhibitorselectivitytowardthehepatocellularcarcinomaassociateddarkkinasestk17b
AT yangshiye understandingtheploopconformationinthedeterminationofinhibitorselectivitytowardthehepatocellularcarcinomaassociateddarkkinasestk17b
AT wangqing understandingtheploopconformationinthedeterminationofinhibitorselectivitytowardthehepatocellularcarcinomaassociateddarkkinasestk17b
AT chaizongtao understandingtheploopconformationinthedeterminationofinhibitorselectivitytowardthehepatocellularcarcinomaassociateddarkkinasestk17b